Tech Company Financing Transactions

GEMMABio Funding Round

GEMMABio, operating out of Philadelphia, received $34 million from Bioluminescence Ventures, Double Point Ventures and Earlybird Venture Capital.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Life Sciences

Mailing Address

125 S. 31st St.
Philadelphia, PA 19104
USA

Phone

(445) 201-3569

Website

www.gemmabiotx.com

Email Address

[email protected]

Overview

GEMMABio, a new therapeutics company, will serve as the research and innovation arm to speed the research of and global access to life-changing advanced therapies for those living with rare diseases. Alongside Franklin Biolabs, GEMMABio will advance gene therapy research and deliver therapeutics to patients around the world significantly faster.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

James Wilson

        

Browse more venture capital transactions:

Prev: 12/23/2024: Avalon Labs venture capital transaction
Next: 12/24/2024: Sitemate venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. All VC database entries on this site come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary